. Diffuse sheets of small, round, blue cells make up this Ewing sarcoma. The cells have a high nucleus-to-cytoplasm ratio and sma ll nucleoli (inset) .
Histologically, ES/PNETs are made up ofdiffuse, densely cellular shee ts of uniform, sma ll to med ium-sized round cells with sca nt vac uolated cytoplas m (figure I). The nuclei are round with a fine, de licate. to coarse chromatin distr ibuti on and sma ll nucleoli (figure 2) . Mitotic figures are co mmo n. Coagul ative necrosis is freq uently identified.
Occasionally there is a grea ter degree of nuclear pleom orphi sm with a rosette formation. Co ncep tually, the tum or is classified as a small, round, blue-cell neoplasm, which requi res the applica tion of spec ial studies to confirm the diagnosis. Th e tumor cells con tain glycogen, which is highl ight ed with a periodic acid-Sc hiff (PAS) stain (figure 2). CD 99 and vimentin are almost always expressed in ES/PNET, while neuron-specific eno lase and sy nap toph ysin are expressed less ofte n. FLI -l (a portio n of the gene fusion produc t of EW S/FLI-I ) ca n be detected by immun ohistochemi stry, although the chara cteri stic chro - mosornal translocati on s at t( II ;22) (q24; q 12) or t(2 l ;22) (q22 ;q 12) ca n be iden tified by polym erase chain reaction or fluorescent in situ hy br idizatio n.
Th e differe ntia ldiagnosis includes other small, round-cell tu mors, such as lymphom a, rhabdom yosarcom a, olfac tory neurobl astoma , melanoma, sino nasa l undi fferent iated carcino ma, and pituitary ade no ma. Different clinical presentation s, pattern s of growth, immunohistochemistry findings , and molecul ar studies allow for se paration.
Tum or stage is one of the most import antco nsiderations in patien ts with this highl y aggressive neopl asm . ES /PNETis managed with multimo da l therapy. Patients with sinonasa l tract lesion s and those with the EWS/FLI-I fusio n tend to have a better prognosis than do patients with thoracoabdo minal lesion s and those witho ut the fusion .
